FAQ/Help |
Calendar |
Search |
Today's Posts |
|
![]() |
#1 | |||
|
||||
Elder
|
I got a "new patients" kit with a letter saying my MD said he was asking me to consider Tysabri, and they wanted me to know more about it. I got a DVD/VHS tape and a booklet. Loads of smiling shiney faced folks in the brochures talking about how wonderful their life is now. They ID the PML risk as 1 in 1000.
I have been complaining that I want to stop C and my MD told me I could go to A or T and and said I would stick with C a while longer. It seems that T is now recruiting me! ![]()
__________________
RRMS 3/26/07 . Betaseron 5/18/07 . Elevated LFTs Beta DC 7/07 Copaxone 8/7/07 . . |
|||
![]() |
![]() |
![]() |
#2 | ||
|
|||
Member
|
Suggest all the Tysabri patients contact MS ActiveSource on Monday and state that we will take no more infusions of Tysabri until they provide us more info on PML cases.
|
||
![]() |
![]() |
![]() |
#3 | ||
|
|||
Member
|
Quote:
A jump in PML cases is concerning, but also remember that Biogen/Elan are testing various assays to diagnose PML earlier and risk stratify patients. It’s possible that these PML cases were identified (in this large clump) as a result of testing patients (those in Trials most likely) with these assays possibly before clinical symptoms. Chris |
||
![]() |
![]() |
"Thanks for this!" says: | ewizabeth (10-28-2009) |
![]() |
#4 | |||
|
||||
Magnate
|
Biogen stopped updating investors on the number of PML cases at the end of July, saying it wanted to focus on the drug's benefits, and would update the medical community at scientific meetings.
Biogen spokeswoman Naomi Aoki declined to comment on whether the figure of 23 cases were consistent with its own records, and she reiterated that the company would not update the public case by case. *According to Reuters*
__________________
. I am not spoiled! |
|||
![]() |
![]() |
"Thanks for this!" says: | Lady (10-24-2009) |
Reply |
Thread Tools | |
Display Modes | |
|
|